New pharmaceutical concepts for sebaceous gland diseases: Implementing today's pre-clinical data into tomorrow's daily clinical practice

Current Pharmaceutical Biotechnology

Volumn 13, Issue 10, 2012, Pages 1898-1913

  Zampeli, Vasiliki A ^a,b   Makrantonaki, Evgenia ^a,b   Tzellos, Thrasivoulos ^c   Zouboulis, Christos C ^a  

^a DESSAU MEDICAL CENTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Acne; Extrinsic ageing; Intrinsic ageing; Muir torre syndrome; Sebaceous carcinoma; Sebaceous gland; Sebaceous hyperplasia

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ANTIINFECTIVE AGENT; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; B RAF KINASE; BETA CATENIN; CBT SL 5; CHIMERIC PROTEIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2B; GROWTH HORMONE; HISTAMINE; LEUKOTRIENE; MELANOCORTIN; MOLECULAR MARKER; NEUROPEPTIDE; PARATHYROID HORMONE RELATED PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN; PROTEIN A FOS; PROTEIN P53; RETINOID; SEX HORMONE; SMAD7 PROTEIN; SONIC HEDGEHOG PROTEIN; SUBSTANCE P; UNCLASSIFIED DRUG; VITAMIN D; WNT PROTEIN;

ACNE; AGING; ARTICLE; ATOPIC DERMATITIS; CLINICAL PRACTICE; CUTANEOUS PARAMETERS; EDA A1 GENE; GENE; HUMAN; INFLAMMATION; LIPID COMPOSITION; MICROSATELLITE INSTABILITY; NONHUMAN; ONCOGENE C MYC; PATHOGENESIS; PROPIONIBACTERIUM ACNES; SEBACEOUS CARCINOMA; SEBACEOUS GLAND; SEBACEOUS GLAND DISEASE; SEBACEOUS GLAND HYPERPLASIA; SEBUM SECRETION; SMOKING; XEROSIS;

ACNE VULGARIS; AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS; DERMATITIS, ATOPIC; HUMANS; IMMUNITY, INNATE; PROPIONIBACTERIUM ACNES; SEBACEOUS GLAND DISEASES; SEBACEOUS GLAND NEOPLASMS;

SOLEIDAE;

EID: 84866679841     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112802273173     Document Type: Article

References (190)

1. Montagna, W. An introduction to sebaceous glands. J. Invest. Dermatol. 1974, 62(3), 120-123.
2. Thody, A.J.; Shuster, S. Control and function of sebaceous glands. Physiol. Rev. 1989, 69(2), 383-416.
3. nded,; Hoath, S.B.; Maibach, H.I., Eds,; Marcel Dekker: New York Basel, 2003, pp. 59-88.
4. Zouboulis, C.C. Acne and sebaceous gland function. Clin. Dermatol. 2004, 22(5), 360-366.
5. Ramasastry, P.; Downing, D.T.; Pochi, P.E.; Strauss, J.S. Chemical composition of human skin surface lipids from birth to puberty. J. Invest. Dermatol. 1970, 54(2), 139-144.
6. Nikkari, T.; Schreibman, P.H.; Ahrens, E.H. Jr. In vivo studies of sterol and squalene secretion by human skin. J. Lipid. Res. 1974, 15(6), 563-573.
7. Picardo, M.; Ottaviani, M.; Camera, E.; Mastrofrancesco, A. Sebaceous gland lipids. Dermatoendocrinol 2009, 1(2), 68-71.
8. Pappas, A. Epidermal surface lipids. Dermatoendocrinol, 2009, 1(2), 72-76.
9. Zouboulis, C.C. The human skin as a hormone target and an endocrine gland. Hormones 2004, 3(1), 9-26.
10. Zouboulis, C.C. The skin as an endocrine organ. Dermatoendocrinol 2009, 1(5), 250-252.
11. Zouboulis, C.C.; Chen, W.; Thornton, M.J.; Qin, K.; Rosenfield, R.L. Sexual hormones in human skin. Horm. Metab. Res. 2007, 39(2), 85-95.
12. Zouboulis, C.C. Sebaceous gland receptors. Dermatoendocrinol 2009, 1(2), 77-80.
13. Chen, W.; Zouboulis, C.C. Hormones and the pilosebaceous unit. Dermatoendocrinol 2009, 1(2), 81-86.
14. Zouboulis, C.C.; Schagen, S.; Alestas, T. The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne. Arch. Dermatol. Res. 2008, 300(8), 397-413.
15. Zouboulis, C.C.; Eady, A.; Philpott, M.; Goldsmith, L.A.; Orfanos, C.; Cunliffe, W.J.; Rosenfield, R. What is the pathogenesis of acne? Exp. Dermatol. 2005, 14(2), 143-152.
16. Zouboulis, C.C.; Baron, J.M.; Böhm, M.; Kippenberger, S.; Kurzen, H.; Reichrath, J.; Thielitz, A. Frontiers in sebaceous gland biology and pathology. Exp. Dermatol. 2008, 17(6), 542-551.
17. Kurokawa, I.; Danby, F.W.; Ju, Q.; Wang, X.; Xiang, L.F.; Xia, L.; Chen, W.; Nagy, I.; Picardo, M.; Suh, D.H.; Ganceviciene, R.; Schagen, S.; Tsatsou, F.; Zouboulis, C.C. New developments in our understanding of acne pathogenesis and treatment. Exp. Dermatol. 2009, 18(10), 821-832.
18. Ghodsi, S.Z.; Orawa, H.; Zouboulis, C.C. Prevalence, severity and severity risk factors of acne in high school pupils: A communitybased study. J. Invest. Dermatol. 2009, 129(9), 2136-2141.
19. Zouboulis, C.C.; Seltmann, H.; Neitzel, H.; Orfanos, C.E. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J. Invest. Dermatol. 1999, 113(6), 1011-1020.
20. Thiboutot, D.; Jabara, S.; McAllister, J.M.; Sivarajah, A.; Gilliland, K.; Cong, Z.; Clawson, G. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J. Invest. Dermatol. 2003, 120(6), 905-914.
21. Lo Celso, C.; Berta, M.A.; Braun, K.M.; Frye, M.; Lyle, S.; Zouboulis, C.C.; Watt, F.M. Characterization of bipotential epidermal progenitors derived from human sebaceous gland: contrasting roles of c-Myc and beta-catenin. Stem Cells 2008, 26(5), 1241-1252.
22. Berger, J.; Moller, D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 2002, 53 409-435.
23. Schmuth, M.; Watson, R.E.; Deplewski, D.; Dubrac, S.; Zouboulis, C.C.; Griffiths, C.E.M. Nuclear hormone receptors in human skin. Horm. Metab. Res., 2007, 39(2), 96-105.
24. 2are active in sebaceous glands. J. Mol. Med. 2006, 84(1), 75-87.
25. Chen, W.; Yang, C.C.; Sheu, H.M.; Seltmann, H.; Zouboulis, C.C. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J. Invest. Dermatol. 2003, 121(3), 441-447.
26. Trivedi, N.R.; Cong, Z.; Nelson, A.M.; Albert, A.J.; Rosamilia, L.L.; Sivarajah, S.; Gilliland, K.L.; Liu, W.; Mauger, D.T.; Gabbay, R.A.; Thiboutot, D.M. Peroxisome proliferator-activated receptors increase human sebum production. J. Invest. Dermatol. 2006, 126(9), 2002-2009.
27. Russell, L.E.; Harrison, W.J.; Bahta, A.W.; Zouboulis, C.C.; Burrin, J.M.; Philpott M.P. Characterization of liver X receptor expression and function in human skin and the pilosebaceous unit. Exp. Dermatol. 2007, 16(10), 844-852.
28. Hong, I.; Lee, M.H.; Na, T.Y.; Zouboulis, C.C.; Lee, M.O. LXRalpha enhances lipid synthesis in SZ95 sebocytes. J. Invest. Dermatol. 2008, 128(5), 1266-1272.
29. Pelle, E.; McCarthy, J.; Seltmann, H.; Huang, X.; Mammone, T.; Zouboulis, C.C.; Maes, D. Identification of histamine receptors and reduction of squalene levels by an antihistamine in sebocytes. J. Invest. Dermatol. 2008, 128(5), 1280-1285.
30. Reichrath, J.; Mittmann, M.; Kamradt, J.; Müller, S.M. Expression of retinoid-X receptors (-alpha,-beta,-gamma) and retinoic acid receptors (-alpha,-beta,-gamma) in normal human skin: an immunohistological evaluation. Histochem. J. 1997, 29(2), 127-133.
31. Tsukada, M.; Schröder, M.; Roos, T.C.; Chandraratna, R.A.; Reichert, U.; Merk, H.F.; Orfanos, C.E.; Zouboulis, C.C. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J. Invest. Dermatol. 2000, 115(2), 321-327.
32. Zouboulis, C.C.; Korge, B.; Akamatsu, H.; Xia, L.Q.; Schiller, S.; Gollnick, H.; Orfanos, C.E. Effects of 13-cis-retinoic acid, alltrans-retinoic acid, and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J. Invest. Dermatol. 1991, 96(5), 792-797.
33. Zouboulis, C.C. Isotretinoin revisited-Pluripotent effects on human sebaceous gland cells. J. Invest. Dermatol., 2006, 126(10), 2154-2156.
34. Nelson, A.; Gilliland, K; Cong, Z; Thiboutot, D. 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J. Invest. Dermatol. 2006, 126(10), 2178-2189.
35. Kim, M.J.; Deplewski, D.; Ciletti, N.; Michel, S.; Reichert, U.; Rosenfield, R.L. Limited cooperation between peroxisome proliferatoractivated receptors and retinoid X receptor agonists in sebocyte growth and development. Mol. Genet. Metab. 2001, 74(3), 362-369.
36. Pappas, A. Diet and acne. Dermatoendocrinol 2009, 1(5), 262-267.
37. Smith, R.N.; Braue, A.; Varigos, G.A.; Mann, N.J. The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J. Dermatol. Sci. 2008, 50(1), 41-52.
38. Melnik, B.C.; Schmitz, G. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp. Dermatol. 2009, 18(10), 833-841.
39. Fritsch, M.; Orfanos, C.E.; Zouboulis, C.C. Sebocytes are the key regulators of androgen homeostasis in human skin. J. Invest. Dermatol. 2001, 116(5), 793-800.
40. Chen, W.; Zouboulis, C.C.; Fritsch, M.; Kodelja, V.; Orfanos, C.E. Heterogeneity and quantitative differences of type 1 5 alphareductase expression in cultured skin epithelial cells. Dermatology 1998, 196(1), 51-52.
41. Fimmel, S.; Saborowski, A.; Térouanne, B.; Sultan, C.; Zouboulis, C.C. Inhibition of the androgen receptor by antisense oligonucleotides regulates the biological activity of androgens in SZ95 sebocytes. Horm. Metab. Res. 2007, 39(2), 149-156.
42. Anderson, K.M.; Liao, S. Selective retention of dihydrotestosterone by prostatic nuclei. Nature 1968, 219(5151), 277-279.
43. Akamatsu, H.; Zouboulis, C.C.; Orfanos, C. Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5-alpha-dihydrotestosterone in vitro. J. Invest. Dermatol. 1993, 100(5), 660-662.
44. Rosenfield, R.; Deplewski, D.; Kentsis, A.; Ciletti, N. Mechanisms of androgen induction of sebocyte differentiation. Dermatology 1998, 196(1), 43-46.
45. Makrantonaki, E.; Zouboulis, C.C. Testosterone metabolism to 5adihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferators-activated receptor ligand linoleic acid in human sebocytes. Br. J. Dermatol. 2007, 156(3), 428-432.
46. Zouboulis, C.C. Human skin: an independent peripheral endocrine organ. Horm. Res. 2000, 54(5-6), 230-242.
47. Strauss, J.S.; Kligman, A.M.; Pochi, P.E. Effect of androgens and estrogens on human sebaceous glands. J. Invest. Dermatol. 1962, 39 139-155.
48. Guy, R.; Ridden, C.; Kealey, T. The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red. J. Invest. Dermatol. 1996, 106(3), 454-460.
49. Deplewski, D.; Rosenfield, R.L. Role of hormones in pilosebaceous unit development. Endocr. Rev. 2000, 21(4), 363-392.
50. Burton, J.L.; Libman, L.J.; Cunliffe, W.J.; Wilkinson, R.; Hall, R.; Shuster, S. Sebum excretion in acromegaly. Br. Med. J. 1972, 1(5797), 406-408.
51. Cappel, M.; Mauger, D.; Thiboutot, D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch. Dermatol. 2005, 141(3), 333-338.
52. Makrantonaki, E.; Vogel, K.; Fimmel, S.; Oeff, M.; Seltmann, H.; Zouboulis, C.C. Interplay of IGF-I and 17beta-estradiol at agespecific levels in human sebocytes and fibroblasts in vitro. Exp. Gerontol. 2008, 43(10), 939-946.
53. Deplewski, D.; Rosenfield, R.L. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999, 140(9), 4089-4094.
54. Smith, T.M.; Cong, Z.; Gilliland, K.L.; Clawson, G.A.; Thiboutot, D.M. Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J. Invest. Dermatol. 2006, 126(6), 1226-1232.
55. Smith, T.M.; Gilliland, K.; Clawson, G.A.; Thiboutot, D. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J. Invest. Dermatol. 2008, 128(5), 1286-1293.
56. Melnik, B.; Schmitz, G. FGFR2 signaling and the pathogenesis of acne. J. Dtsch. Dermatol. Ges. 2008, 6(9), 721-728.
57. Melnik, B.C.; Vakilzadeh, F.; Aslanidis, C.; Schmitz, G. Unilateral segmental acneiform naevus: a model disorder towards understanding fibroblast growth factor receptor 2 function in acne? Br. J. Dermatol. 2008, 158(6), 1397-1399.
58. Melnik, B.C. Role of FGFR2-signaling in the pathogenesis of acne. Dermatoendocrinol 2009, 1(3), 141-156.
59. Melnik B.C.; Schmitz, G.; Zouboulis, C.C. Anti-acne agents attenuate FGFR2 signal transduction in acne. J. Invest. Dermatol. 2009, 129(8), 1868-1877.
60. Krämer, C.; Seltmann, H.; Seifert, M.; Tilgen, W.; Zouboulis, C.C.; Reichrath, J. Characterization of the vitamin D endocrine system in human sebocytes in vitro. J. Steroid. Biochem. Mol. Biol. 2009, 113(1-2), 9-16.
61. Ganceviciene, R.; Graziene, V.; Fimmel, S.; Zouboulis, C.C. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br. J. Dermatol. 2009, 160(2), 345-352.
62. Zouboulis, C.C.; Seltmann, H.; Hiroi, N.; Chen, W.; Young, M.; Oeff, M.; Scherbaum, W.A.; Orfanos, C.E.; McCann, S.M.; Bornstein, S.R. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc. Natl. Acad. Sci. USA 2002, 99(10), 7148-7153.
63. Krause, K.; Schnitger, A.; Fimmel, S.; Glass, E.; Zouboulis, C.C. Corticotropin-releasing hormone skin signaling is receptormediated and is predominant in the sebaceous glands. Horm. Metab. Res. 2007, 39(2), 166-170.
64. Böhm, M.; Schiller, M.; Ständer, S.; Seltmann, H.; Li, Z.; Brzoska T.; Metze, D.; Schiöth, H.B.; Skottner, A.; Seiffert, K.; Zouboulis, C.C.; Luger, T.A. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J. Invest. Dermatol. 2002, 118(3), 533-539.
65. Lipton, J.M.; Catania, A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol. Today 1997, 18(3), 140
66. Zhang, L.; Li, W.; Anthonavage, M.; Eisinger, M. Melanocortin-5 receptor: A marker of human sebocyte differentiation. Peptides. 2006, 27(2), 413-420.
67. Ständer, S.; Schmelz, M.; Metze, D.; Luger, T.; Rukwied, R. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J. Dermatol. Sci. 2005, 38(3), 177-188.
68. Dobrosi, N.; Tóth, B.I.; Nagy, G.; Dózsa, A.; Géczy, T.; Nagy, L.; Zouboulis, C.C.; Paus, R.; Kovács, L.; Bíró, T. Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. FASEB. J. 2008, 22(10), 3685-36895.
69. Toyoda, M.; Nakamura, M.; Morohashi, M. Neuropeptides and sebaceous glands. Eur. J. Dermatol. 2002, 12(5), 422-427.
70. Toyoda, M.; Nakamura, M.; Makino, T.; Kagoura, M.; Morohashi, M. Sebaceous glands in acne patients express high levels of neutral endopeptidase. Exp. Dermatol. 2002, 11(3), 241-247.
71. Ansorge, S.; Reinhold, D.; Lendeckel, U. Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells. Z. Naturforsch. 2003, 58(7-8), 580-589.
72. Thielitz, A.; Reinhold, D.; Vetter, R.; Bank, U.; Helmuth, M.; Hartig, R.; Wrenger, S.; Wiswedel, I.; Lendeckel, U.; Kähne, T.; Neubert, K.; Faust, J.; Zouboulis, C.C.; Ansorge, S.; Gollnick, H. Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation. J. Invest. Dermatol. 2007, 127(5), 1042-1051.
73. Zouboulis, C.C. Is acne vulgaris a genuine inflammatory disease? Dermatology 2001, 203(4), 277-279.
74. Hindson, C.; Lawlor, F.; Wacks, H. Benoxaprofen for nodular acne. Lancet 1982, 1(8286), 1415.
75. Wong, R.C.; Kang, S.; Heezen, J.L.; Voorhees, J.J.; Ellis, C.N. Oral ibuprofen and tetracycline for the treatment of acne vulgaris. J. Am. Acad. Dermatol. 1984, 11(6), 1076-1081.
76. Karvonen, S.L.; Vaalasti, A.; Kautiainen, H.; Reunala, T. Systemic corticosteroid and isotretinoin treatment in cystic acne. Acta Derm. Venereol. 1993, 73(6), 452-455.
77. Seukeran, D.C.; Cunliffe, W.J. The treatment of acne fulminans: a review of 25 cases. Br. J. Dermatol. 1999, 141(2), 307-309.
78. Bass, D.; Zouboulis, C.C. Behandlung der Acne fulminans mit Isotretinoin und Prednisolon. Z. Hautkr. 2001, 76 473.
79. Ingham, E.; Eady, E.A.; Goodwin, C.E.; Cove, J.H.; Cunliffe, W.J. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J. Invest. Dermatol. 1992, 98(6), 895-901.
80. Boehm, K.D.; Yun, J.K.; Strohl, K.P.; Elmets, C.A. Messenger RNAs for the multifunctional cytokines interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha are present in adnexal tissues and in dermis of normal human skin. Exp. Dermatol., 1995, 4(6), 335-341.
81. Guy, R.; Green, M.R.; Kealey, T. Modeling acne in vitro. J. Invest. Dermatol. 1996, 106(1), 176-182.
82. Zouboulis, C.C.; Xia, L.; Akamatsu, H.; Seltmann, H.; Fritsch, M.; Hornemann, S.; Rühl, R.; Chen, W.; Nau, H.; Orfanos, C.E. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 1998, 196(1), 21-31.
83. Jeremy, A.H.; Holland, D.B.; Roberts, S.G.; Thomson, K.F.; Cunliffe, W.J. Inflammatory events are involved in acne lesion initiation. J. Invest. Dermatol. 2003, 121(1), 20-27.
84. Trivedi, N.R.; Gilliland, K.L.; Zhao, W.; Liu, W.; Thiboutot, D.M. Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J. Invest. Dermatol. 2006, 126(5), 1071-1079.
85. Papakonstantinou, E.; Aletras, A.J.; Glass, E.; Tsogas, P.; Dionyssopoulos, A.; Adjaye, J.; Fimmel, S.; Gouvousis, P.; Herwig, R.; Lehrach, H.; Zouboulis, C.C.; Karakiulakis, G. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J. Invest. Dermatol. 2005, 125(4), 673-684.
86. Yamamoto, Y.; Gaynor, R. Role of the NFB pathway in the pathogenesis of human disease states. Curr. Mol. Med. 2001, 1(3), 287-296.
87. Boone, D.; Lee, E.; Libby, S.; Gibson, P.; Chien, M.; Chan, F.; Madonia, M.; Burkett, P.; Ma, A. Recent advances in understanding NFB regulation. Inflamm. Bowel. Dis. 2002, 8(3), 201-212.
88. Kang, S.; Cho, S.; Chung, J.H.; Hammerberg, C.; Fisher, G.J.; Voorhees, J.J. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am. J. Pathol. 2005, 166(6), 1691-1699.
89. Szabó, K.; Tax, G.; Teodorescu-Brinzeu, D.; Koreck, A.; Kemény, L. TNFalpha gene polymorphisms in the pathogenesis of acne vulgaris. Arch. Dermatol. Res. 2011, 303(1),19-27.
90. Marta Guarna, M.; Coulson, R.; Rubinchik, E. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris. FEMS Microbiol. Lett. 2006, 257(1), 1-6.
91. Zhang, Q.; Seltmann, H.; Zouboulis, C.C.; Travers, J.B. Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production. Exp. Dermatol. 2006, 15(10), 769-774.
92. 4: Metabolism and signal transduction. Arch. Biochem. Biophys. 2001, 385(2), 231-241.
93. Haeggstrom, J.Z. Leukotriene A4 hydrolase/aminopeptidase, the gatekeeper of chemotactic LTB4 biosynthesis. J. Biol. Chem. 2004, 279(49), 50639-50642.
94. Devchand, P.R.; Keller, H.; Peters, J.M.; Vazquez, M.; Gonzalez, F.J.; Wahli, W. The PPAR-alpha leukotriene-B4 pathway to inflammation control. Nature 1996, 384(6604), 39-43.
95. Delerive, P.; Fruchart, J.C.; Staels, B. Eurosterone Meeting-Peroxisome proliferators activated receptors in inflammation control. J. Endocrinol. 2001, 169(3), 453-459.
96. Zouboulis, C.C. Leukotrien-Antagonisten bei atopischen Erkrankungen und Akne. Akt. Dermatol. 2003, 29 419-425.
97. Zouboulis, C.C.; Seltmann, H.; Alestas, T. Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous lipogenesis. Exp. Dermatol. 2010, 19(2), 148-150.
98. Zouboulis, C.C.; Nestoris, S.; Adler, Y.D.; Picardo, M.; Camera, E.; Orth, M.; Orfanos, C.E.; Picardo, M.; Camera, E.; Cunliffe, W.J. A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol. 2003, 139(5), 668-670.
99. Zouboulis, C.C.; Saborowski, A.; Boschnakow, A. Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 2005, 210(1), 36-38.
100. Beveridge, T.J. Mechanism of gram variability in select bacteria. J. Bacteriol., 1990, 172(3), 1609-1620.
101. Kamisango, K.; Saiki, I.; Tanio, Y.; Okumura, H.; Araki, Y.; Sekikawa, I.; Azuma, I.; Yamamura, Y. Structures and biological activities of peptidoglycans of Listeria monocytogenes and Propionibacterium acnes. J. Biochem. 1982, 92(1), 23-33.
102. Zouboulis, C.C. Propionibacterium acnes and sebaceous lipogenesis: A love-hate relationship? J. Invest. Dermatol. 2009, 129(9), 2113-2119.
103. Brüggemann, H.; Henne, A.; Hoster, F.; Liesegang, H.; Wiezer, A.; Strittmatter, A.; Hujer, S.; Duerre, P.; Gottschalk, G. The complete genome sequence of Propionibacterium acnes a commensal of human skin. Science 2004, 305(5684), 671-673.
104. Nakatsuji, T.; Liu, Y.T.; Huang, C.P.; Zouboulis, C.C.; Gallo, R.L.; Huang, C.M. Vaccination targeting a surface sialidase of P. acnes: Implication for new treatment of acne vulgaris. PloS ONE. 2008, 3(2), e1551.
105. Koreck, A.; Dobozy, A.; Kemeny, L. The role of innate immunity in the pathogenesis of acne. Dermatology 2003, 206(2), 96-105.
106. Burkhart, C.G.; Cantrill, J.; Butcher, C.L.; Lehmann, P.F. Propionibacterium acnes: interaction with complement and development of an enzyme-linked immunoassay for the detection of antibody. Int. J. Dermatol. 1999, 38(3), 200-203.
107. Downing, D.; Stewart, M.; Wertz, P.; Strauss, J. Essential fatty acids and acne. J. Am. Acad. Dermatol. 1986, 14(2 Pt 1), 221-225.
108. Sugisaki, H.; Yamanaka, K.; Kakeda, M.; Kitagawa, H,; Tanaka, K.; Watanabe, K.; Gabazza, E.C.; Kurokawa, I.; Mizutani, H. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. J. Dermatol. Sci. 2009, 55(1), 47-52.
109. Vowels, B.R.; Yang, S.; Leyden, J.J. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect. Immun. 1995, 63(8), 3158-3165.
110. Kim, J.; Ochoa, M.T.; Krutzik, S.R.; Takeuchi, O.; Uematsu, S.; Legaspi, A.J.; Brightbill, H.D.; Holland, D.; Cunliffe, W.J.; Akira, S.; Sieling, P.A.; Godowski, P.J.; Modlin, R.L. Activation of tolllike receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 2002, 169(3), 1535-1541.
111. Oeff, M.K.; Seltmann, H.; Hiroi, N.; Nastos, A.; Makrantonaki, E.; Bornstein, S.R.; Zouboulis, C.C. Differential regulation of Toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology 2006, 213(3), 266.
112. Kim, J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 2005, 211(3), 193-198.
113. Chronnell, C.M.; Ghali, L.R.; Ali, R.S.; Quinn, A.G.; Holland, D.B.; Bull, J.J.; Cunliffe, W.J.; McKay, I.A.; Philpott, M.P.; Müller-Röver, S. Human beta defensin-1 and-2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J. Invest. Dermatol. 2001, 117(5), 1120-1125.
114. Lee, D.Y.; Yamasaki, K.; Rudsil, J.; Zouboulis, C.C.; Park, G.T.; Yang, J.M.; Gallo, R.L. Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill propionibacterium acnes. J. Invest. Dermatol. 2008, 128(7), 1863-1866.
115. Nagy, I.; Pivarcsi, A.; Kis, K.; Koreck, A.; Bodai, L.; McDowell, A.; Seltmann, H.; Patrick, S.; Zouboulis, C.C.; Kemény, L. Propionibacterium acnes and lipopolysaccharide induce the expression of antibacterial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microb. Infect. 2006, 8(8), 2195-2205.
116. Georgel, P.; Crozat, K.; Lauth, X.; Makrantonaki, E.; Seltmann, H.; Sovath, S.; Hoebe, K.; Du, X.; Rutschmann, S.; Jiang, Z.; Bigby, T.; Nizet, V.; Zouboulis, C.C.; Beutler, B. A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect. Immun. 2005, 73(8), 4512-4521.
117. Wille, J.J.; Kydonieus, A. Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria. Skin Pharmacol. Appl. Skin Physiol. 2003, 16(3), 176-187.
118. Nakatsuji, T.; Kao, M.C.; Fang, J.-Y.; Zouboulis, C.C.; Zhang, L.; Gallo, R.L.; Huang, C.M. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J. Invest. Dermatol. 2009, 129(10), 2480-2488.
119. Nakatsuji, T.; Kao, M.C.; Zhang, L.; Zouboulis, C.C.; Gallo, R.L.; Huang, C.M. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating-defensin-2 expression. J. Invest. Dermatol. 2010, 130 (4), 985-994.
120. Grange, P.A.; Raingeaud, J.; Calvez, V.; Dupin, N. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways. J. Dermatol. Sci. 2009, 56(2), 106-112.
121. Lee, Y.J.; Choi, H.J.; Kang, T.W.; Kim, H.O.; Chung, M.J.; Park, Y.M. CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes. J. Microbiol. Biotechnol., 2008, 18(7), 1308-1316.
122. Nakatsuji, T.; Liu, Y.T.; Huang, C.P.; Zouboulis, C.C.; Gallo, R.L.; Huang, C.M. Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris. J. Invest. Dermatol. 2008, 128(10), 2451-2457.
123. Capitanio, B.; Sinagra, J.L.; Bordignon, V.; Cordiali Fei, P.; Ensoli, F.; Picardo, M.; Zouboulis, CC. Underestimated clinical features of post adolescent acne. J. Am. Acad. Dermatol., 2010, 63(5), 782-788.
124. Tzellos, T.G.; Klagas, I.; Vahtsevanos, K.; Triaridis, S.; Printza, A.; Kyrgidis, A.; Karakiulakis, G.; Zouboulis, C.C.; Papakonstantinou, E. Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes. Exp. Dermatol. 2009, 18(12), 1028-1035.
125. Makrantonaki, E.; Zouboulis, C.C. German National Genome Research Network 2. The skin as a mirror of the aging process in the human organism-state of the art and results of the aging research in the German National Genome Research Network 2 (NGFN-2). Exp. Gerontol. 2007, 42(9), 879-886.
126. Makrantonaki, E.; Zouboulis, C.C. Molecular mechanisms of skin aging: state of the art. Ann. NY Acad. Sci. 2007, 1119 40-50.
127. Zouboulis, C.C.; Boschnakow, A. Chronological ageing and photoageing of the human sebaceous gland. Clin. Exp. Dermatol. 2001, 26(7), 600-607.
128. Pochi, P.E.; Strauss, J.S.; Downing D.T. Age-related changes in sebaceous gland activity. J. Invest. Dermatol. 1979, 73(1), 108-111.
129. Yamamoto, A.; Serizawa, S.; Ito, M.; Sato, Y. Effect of aging on sebaceous gland activity and on the fatty composition of wax esters. J. Invest. Dermatol. 1987, 89(5), 507-512.
130. Stewart, M.E.; Steele, W.A.; Downing, D.T. Changes in the relative amounts of endogenous and exogenous fatty acids in sebaceous lipids during early adolescence. J. Invest. Dermatol. 1989, 92(3), 371-378.
131. Fenske, N.A.; Lober, C.W. Structural and functional changes of normal aging skin. J. Am. Acad. Dermatol. 1986, 15(4 Pt 1), 571-585.
132. Plewig, G.; Kligman, A.M. Proliferative activity of the sebaceous glands of the aged. J. Invest. Dermatol. 1978, 70(6), 314-317.
133. Tavakkol, A.; Varani, J.; Elder, J.T.; Zouboulis, C.C. Maintenance of human skin in organ culture: Role for insulin-like growth factor-1 receptor and epidermal growth factor receptor. Arch. Dermatol. Res. 1999, 291(12), 643-651.
134. Brincat, M.; Versi, E.; O'Dowd, T.; Moniz, C.F.; Magos, A.; Kabalan, S.; Studd, J.W. Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitas. 1987, 9(1), 1-5.
135. Creidi, P.; Faivre, B.; Agache, P.; Richard, E.; Haudiquet, V.; Sauvanet, J.P. Effect of a conjugated oestrogen (Premarin) cream on ageing facial skin. A comparative study with a placebo cream. Maturitas. 1994, 19(3), 211-223.
136. Makrantonaki, E.; Vogel, K.; Fimmel, S.; Oeff, M.; Seltmann, H.; Zouboulis, C.C. Interplay of IGF-I and 17beta-estradiol at agespecific levels in human sebocytes and fibroblasts in vitro. Exp. Gerontol. 2008, 43(10), 939-946.
137. Makrantonaki, E.; Adjaye, J.; Herwig, R.; Brink, T.C.; Groth, D.; Hultschig, C.; Lehrach, H.; Zouboulis, C.C. Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell. 2006, 5(4), 331-344.
138. Ponti, G.; Venesio, T.; Losi, L.; Pellacani, G.; Bertario, L.; Sala, P.; Pedroni, M.; Petti, C.; Maffei, S.; Varesco, L.; Lerch, E.; Baggio, A.; Bassoli, S.; Longo, C.; Seidenari, S. BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees. J. Invest. Dermatol. 2007, 127(6), 1387-1391.
139. de Berker, D.A.; Taylor, A.E.; Quinn, A.G.; Simpson, N.B. Sebaceous hyperplasia in organ transplant recipients: shared aspects of hyperplastic and dysplastic processes? J. Am. Acad. Dermatol. 1996, 35(5 Pt 1), 696-699.
140. Boschnakow, A.; May, T.; Assaf, C.; Tebbe, B.; Zouboulis, C.C. Ciclosporin A-induced sebaceous gland hyperplasia. Br. J. Dermatol. 2003, 149(1), 198-200.
141. Pang, S.M.; Chau, Y.P. Cyclosporin-induced sebaceous hyperplasia in renal transplant patients. Ann. Acad. Med. Singapore 2005, 34(5), 391-393.
142. Shalin, S.C.; Lyle, S.; Calonje, E.; Lazar, A.J. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications. Histopathology 2010, 56(1), 133-147.
143. Lesnik, R.H.; Kligman, L.H.; Kligman, A.M. Agents that cause enlargement of sebaceous glands in hailess mice. II. Ultraviolet radiation. Arch. Dermatol. Res. 1992, 284(2), 106-108.
144. Bayer-Garner, I.B.; Givens, V.; Smoller, B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am. J. Dermatopathol. 1999, 21(5), 426-431.
145. Kyrgidis, A.; Tzellos, T.G.; Triaridis, S. Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications. J Carcinog. 2010, 9 3.
146. Kyrgidis, A.; Tzellos, T.G.; Vahtsevanos, K.; Triaridis, S. New concepts for basal cell carcinoma. Demographic, clinical, histological risk factors and biomarkers. A systematic review of evidence regarding risk for tumor development, susceptibility for second primary and recurrence. J. Surg. Res. 2010, 159(1), 545-556.
147. Davies, H.; Bignell, G.R.; Cox, C.; Stephens, P.; Edkins, S.; Clegg, S.; Teague, J.; Woffendin, H.; Garnett, M.J.; Bottomley, W.; Davis, N.; Dicks, E.; Ewing, R.; Floyd, Y.; Gray, K.; Hall, S.; Hawes, R.; Hughes, J.; Kosmidou, V.; Menzies, A.; Mould, C.; Parker, A.; Stevens, C.; Watt, S.; Hooper, S.; Wilson, R.; Jayatilake, H.; Gusterson, B.A.; Cooper, C.; Shipley, J.; Hargrave, D.; Pritchard-Jones, K.; Maitland, N.; Chenevix-Trench, G.; Riggins, G.J.; Bigner, D.D.; Palmieri, G.; Cossu, A.; Flanagan, A.; Nicholson, A.; Ho, J.W.; Leung, S.Y.; Yuen, S.T.; Weber, B.L.; Seigler, H.F.; Darrow, T.L.; Paterson, H.; Marais, R.; Marshall, C.J.; Wooster, R.; Stratton, M.R.; Futreal, P.A. Mutations of the BRAF gene in human cancer. Nature 2002, 417(6892), 949-954.
148. Horsley, V.; O'Carroll, D.; Tooze, R.; Ohinata, Y.; Saitou, M.; Obukhanych, T.; Nussenzweig, M.; Tarakhovsky, A.; Fuchs, E. Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell 2006, 126(3), 597-609.
149. Butt, A.J.; McNeil, C.M.; Musgrove, E.A.; Sutherland, R.L. Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr. Relat. Cancer 2005, 1: S47-S59.
150. Arnold, I.; Watt, F.M. c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr. Biol., 2001, 11(8), 558-568.
151. Zanet, J.; Pibre, S.; Jacquet, C.; Ramirez, A.; de Alborán, I.M.; Gandarillas, A. Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification. J. Cell. Sci. 2005, 118(Pt 8), 1693-1704.
152. He, W.; Wang, D.; Ten Dijke, P.; Wang, X.J. Overexpression of Smad7 in the epidermis of transgenic mice results in development defects in the epidermis and its appendages. J. Invest. Dermatol. 2001, 21(11), 2580-2590.
153. Foley, J.; Longely, B.J.; Wysolmerski, J.J.; Dreyer, B.E.; Broadus, A.E.; Philbrick, W.H. PTHrP regulates epidermal differentiation in adult mice. J. Invest. Dermatol. 1998, 111(6), 1122-1128.
154. Vinson, C.; Myakishev, M.; Acharya, A.; Mir, A.A.; Moll, J.R.; Bonovich, M. Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell. Biol. 2002, 22(18), 6321-6335.
155. Gerdes, M.J.; Myakishev, M.; Frost, N.A.; Rishi, V.; Moitra, J.; Acharya, A.; Levy, M.R.; Park, S.W.; Glick, A.; Yuspa, S.H.; Vinson, C. Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res. 2006, 66(15), 7578-7588.
156. Brasaemle, D.L.; Barber, T.; Wolins, N.E.; Serrero, G.; Blanchette-Mackie, E.J.; Londos, C. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J. Lipid. Res. 1997, 38(11), 2249-2263.
157. Cui, C.Y.; Durmowicz, M.; Ottolenghi, C.; Hashimoto, T.; Griggs, B.; Srivastava, A.K.; Schlessinger, D. Inducible mEDA-A1 transgene mediates sebaceous gland hyperplasia and differential formation of two types of mouse hair follicles. Hum. Mol. Genet. 2003, 12(22), 2931-2940.
158. Mikkola, M.L.; Pispa, J.; Pekkanen, M.; Paulin, L.; Nieminen, P.; Kere, J.; Thesleff, I. Ectodysplasin, a protein required for epithelial morphogenesis, is a novel TNF homologue and promotes cellmatrix adhesion. Mech. Dev. 1999, 88(2), 133-146.
159. Gonzalez-Fernandez, F.; Kaltreider, S.A.; Patnaik, B.D.; Retief, J.D.; Bao, Y.; Newman, S.; Stoler, M.H.; Levine, P.A. Sebaceous carcinoma. Tumor progression through mutational inactivation of p53. Ophthalmology 1998, 105(3), 497-506.
160. Harwood, C.A.; Swale, V.J.; Bataille, V.A.; Quinn, A.G.; Ghali, L.; Patel, S.V.; Dove-Edwin, I.; Cerio, R.; McGregor, J.M. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients. J. Invest. Dermatol. 2001, 116(2), 246-253.
161. Ponti, G.; Ponz de Leon, M. Muir-Torre syndrome. Lancet Oncol. 2005, 6(12), 980.
162. Nanney, L.B.; Magid, M.; Stoscheck, M.C.; King, L.E. Jr. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J. Invest. Dermatology. 1984, 83(5), 385.
163. Ivan, D.; Prieto, V.G.; Esmaeli, B.; Wistuba, I.I.; Tang, X.; Lazar, A.J. Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma. J. Cutan. Pathol. 2010, 37(2), 231-236.
164. Wakabayashi, A.; Tanese, K.; Yamamoto, K.; Tanomogi, H.; Miyakawa, S. Extraocular sebaceous carcinoma expressing oestrogen receptor alpha and human epidermal growth factor receptor 2. Clin. Exp. Dermatol. 2009, 35(5),546-548.
165. Tomková, H.; Kohoutek, M.; Zábojníková, M.; Pospísková, M.; Ostrízková, L.; Gharibyar, M. Cetuximab-induced cutaneous toxicity. J. Eur. Acad. Dermatol. Venereol. 2010, 24(6), 692-696.
166. Kiyosaki, K.; Nakada, C.; Hijiya, N.; Tsukamoto, Y.; Matsuura, K.; Nakatsuka, K.; Daa, T.; Yokoyama, S.; Imaizumi, M.; Moriyama, M. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. Invest. Ophthalmol. Vis. Sci. 2010, 51(1), 7-11.
167. McBride, S.R.; Leonard, N.; Reynolds, N.J. Loss of p21(WAF1) compartmentalisation in sebaceous carcinoma compared with sebaceous hyperplasia and sebaceous adenoma. J. Clin. Pathol. 2002, 55(10), 763-766.
168. Inga, A.; Scott, G.; Monti, P.; Aprile, A.; Abbondandolo, A.; Burns, P.A.; Fronza, G. Ultraviolet-light induced p53 mutational spectrum in yeast is indistinguishable from p53 mutations in human skin cancer. Carcinogenesis 1998, 19(5), 741-746.
169. Borresen-Dale, A.L. TP53 and breast cancer. Hum. Mutat. 2003, 21(3), 292-300.
170. Peltomaki, P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J. Clin. Oncol. 2003, 21(6), 1174-1179.
171. Kruse, R.; Ruzicka, T. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention. Trends Mol. Med. 2004, 10(3), 136-141.
172. Kruse, R.; Rutten, A.; Schweiger, N.; Jakob, E.; Mathiak, M.; Propping, P.; Mangold, E.; Bisceglia, M.; Ruzicka. T. Frequency of microsatellite instability in unselected sebaceous gland neoplasia and hyperplasia. J. Invest. Dermatol. 2003, 120(5), 858-864.
173. Mathiak, M.; Rütten, A.; Mangold, E.; Fischer, H.P.; Ruzicka, T.; Friedl, W.; Propping, P.; Kruse, R. Loss of DNA mismatch repair proteins in skin tumors from patients wih Muir Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am. J. Surg. Pathol. 2002, 26(3), 338-343.
174. Niemann, C.; Unden, A.B.; Lyle, S.; Zouboulis, Ch.C.; Toftgard, R.; Watt, F.M. Indian hedgehog and beta-catenin signaling: role in the sebaceous lineage of normal and neoplastic mammalian epidermis. Proc. Natl. Acad. Sci. USA 2003, 100 11873-11880.
175. Morita, K.; Lo Celso, C.; Spencer-Dene, B.; Zouboulis, C.C.; Watt, F.M. HAN11 binds mDia1 and controls Gli1 transcriptional activity. J. Derm. Sci. 2006, 44(1), 11-20.
176. Gat, U.; DasGupta, R.; Degenstein, L.; Fuchs, E. De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 1998, 95(5), 605-614.
177. Niemann, C.; Owens, D.M.; Hulsken, J.; Birchmeier, W.; Watt, F.M. Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours. Development 2002, 129(1), 95-109.
178. Takeda, H.; Lyle, S.; Lazar, A.J.; Zouboulis, C.C.; Smyth, I.; Watt, F.M. Human sebaceous tumors harbor inactivating mutations in LEF1. Nat. Med. 2006, 12(4), 395-397.
179. Schaich, B.; Korting, H.C.; Hollmann, J. Skin lipids in seborrhea-and sebostasis associated skin diseases. Hautarzt. 1993, 44(2), 75-80.
180. Yamamoto, A.; Serizawa, S.; Ito, M.; Sato, Y. Stratum corneum lipid abnormalities in atopic dermatitis. Arch. Dermatol. Res. 1991, 283(4), 219-223.
181. Ead, R.D.; Fairbank, R.A.; Cunliffe, W.J. Sebum excretion rate, surface lipid composition and constitutional eczema. Clin. Exp. Dermatol. 1977, 2(4), 361-364.
182. Saint-Leger, D.; Francois, A.M.; Leveque, J.L.; Stoudemayer, T.J.; Kligman, A.M.; Grove, G. Stratum corneum lipids in skin xerosis. Dermatologica 1989, 178(3), 151-155.
183. Hatano, Y.; Man, M.Q.; Uchida, Y.; Crumrine, D.; Mauro, T.M.; Feingold, K.R.; Elias, P.M.; Holleran, W.M. Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators. J. Allergy Clin. Immunol. 2010, 125(1), 160-169.
184. Werner, B.; Brenner, F.M.; Böer, A. Histopathologic study of scalp psoriasis: peculiar features including sebaceous gland atrophy. Am. J. Dermatopathol. 2008, 30(2), 93-100.
185. Headington, J.T.; Gupta, A.K.; Goldfarb, M.T.; Nickoloff, B.J.; Hamilton, T.A.; Ellis, C.N.; Voorhees, J.J. A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia. Arch. Dermatol. 1989, 125(5), 639-642.
186. Runne, U.; Kroneisen-Wiersma, P. Psoriatic alopecia: acute and chronic hair loss in 47 patients with scalp psoriasis. Dermatology 1992, 185(2), 82-87.
187. Wilson, C.L.; Dean, D.; Lane, E.B.; Dawber, R.P.; Leigh, I.M. Keratinocyte differentiation in psoriatic scalp: morphology and expression of epithelial keratins. Br. J. Dermatol. 1994, 131(2), 191-200.
188. Bardazzi, F.; Fanti, P.A.; Orlandi, C.; Chieregato, C.; Misciali, C. Psoriatic scarring alopecia: observations in four patients. Int. J. Dermatol. 1999, 38(10), 765-768.
189. Shahrad, P.; Marks, R. Hair follicle kinetics in psoriasis. Br. J. Dermatol. 1976, 94(1), 7-12.
190. Huang, J.; Li, G.; Xiang, J.; Yin, D.; Chi, R. Immunohistochemical study of serotonin in lesions of psoriasis. Int. J. Dermatol. 2004, 43(6), 408-411.